Minoru Kanke, MD | Authors

HELEN KELLER MEM HOSP PHCY

PO BOX 610

1300 S MONTGOMERY AVE STE 610

Articles

UFT Plus Carboplatin for Head and Neck Cancer

October 01, 2000

Cisplatin plus fluorouracil (5-FU) is widely accepted as neoadjuvant and adjuvant chemotherapy in the treatment of head and neck squamous cell carcinoma; UFT is also an active agent against this disease. In the first retrospective study, we examined the efficacy of UFT as adjuvant chemotherapy in patients with maxillary cancer.